Results 301 to 310 of about 3,938,965 (348)
Some of the next articles are maybe not open access.
Antifungal drugs on the horizon
Journal of the American Academy of Dermatology, 1994In the past 10 years there has been a major expansion in the development of antifungal drugs, but there are still weaknesses in the range and scope of current antifungal chemotherapy. New developments have included the modification of existing drug molecules to eliminate toxicity and improve activity, for instance, the development of the lipid ...
openaire +3 more sources
Pediatrics In Review, 2016
1. Lynn Smitherman, MD* 1. *Wayne State University School of Medicine, Detroit, MI. 1. 1. Tay E. Azole Antifungal Agents. Tay E. Pediatr Rev. 2005;26(1):20–21 [OpenUrl][1][FREE Full Text][2] 2. 1. Jura S, 2. Hillenbrand K. Fluconazole. Jura S, Hillenbrand K. Pediatr Rev. 2006;27(4):158–159 [OpenUrl][3]
openaire +3 more sources
1. Lynn Smitherman, MD* 1. *Wayne State University School of Medicine, Detroit, MI. 1. 1. Tay E. Azole Antifungal Agents. Tay E. Pediatr Rev. 2005;26(1):20–21 [OpenUrl][1][FREE Full Text][2] 2. 1. Jura S, 2. Hillenbrand K. Fluconazole. Jura S, Hillenbrand K. Pediatr Rev. 2006;27(4):158–159 [OpenUrl][3]
openaire +3 more sources
Antifungal Drugs and Resistance
1995From the late 1950’s, extending for two decades thereafter, amphotericin B was the only broad spectrum antifungal drug which could be systemically administered. Because it was the only option, and because systemic mycoses were relatively infrequent, there was little interest in understanding the mechanism of action of amphotericin B, or expanding ...
openaire +3 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Resistance to Antifungal Drugs
2003Abstract Fungal infections caused by fungal pathogens remain quite common in immunocompromised hosts, especially in HIV-infected individuals, and in patients given immunosuppressive drugs or broad-spectrum antibiotics. Candida spp. represent the major group of yeast species recovered from these infected individuals; however, other yeasts
openaire +2 more sources
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
2012
There are a number of antifungal drugs authorised for use in animals, the majority being members of the polyene or azole classes. Of these, only two are permitted for use in food animals, at least in the European Union, natamycin and enilconazole. Griseofulvin is a cyclohexenone derivative which has been used in companion and food animal medicine ...
openaire +2 more sources
There are a number of antifungal drugs authorised for use in animals, the majority being members of the polyene or azole classes. Of these, only two are permitted for use in food animals, at least in the European Union, natamycin and enilconazole. Griseofulvin is a cyclohexenone derivative which has been used in companion and food animal medicine ...
openaire +2 more sources